• LAST PRICE
    22.1200
  • TODAY'S CHANGE (%)
    Trending Up0.2600 (1.1894%)
  • Bid / Lots
    21.3100/ 2
  • Ask / Lots
    29.9800/ 1
  • Open / Previous Close
    22.0000 / 21.8600
  • Day Range
    Low 21.4700
    High 22.2100
  • 52 Week Range
    Low 4.0000
    High 31.0100
  • Volume
    76,310
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 21.86
TimeVolumeJSPR
09:32 ET31122
09:41 ET10021.95
09:43 ET20021.72
09:45 ET10021.74
09:48 ET65921.75
09:50 ET20021.97
09:52 ET42521.6
09:54 ET10021.84
09:56 ET10021.81
09:57 ET40021.93
09:59 ET20021.94
10:01 ET30021.61
10:03 ET10021.91
10:06 ET20021.87
10:08 ET10021.86
10:12 ET10021.97
10:14 ET20021.8212
10:15 ET10021.96
10:17 ET20021.94
10:19 ET10021.87
10:21 ET10021.89
10:24 ET21021.81
10:26 ET20021.86
10:28 ET180421.91
10:42 ET130421.89
10:53 ET60021.85
11:02 ET10021.95
11:09 ET10021.96
11:15 ET60021.858
11:20 ET10021.94
11:27 ET70021.82
11:29 ET20021.92
11:42 ET10021.92
11:44 ET10021.92
11:45 ET40021.915
11:51 ET10021.915
12:03 ET30022
12:23 ET90021.98
12:38 ET100021.92
12:54 ET10021.915
12:57 ET104721.92
12:59 ET40021.97
01:21 ET20021.87
01:30 ET50021.86
01:35 ET10021.97
01:44 ET80021.885
01:57 ET10022
02:02 ET10021.915
02:09 ET39921.92
02:13 ET10021.96
02:20 ET40021.98
02:40 ET88421.99
02:49 ET10021.99
03:03 ET20021.995
03:09 ET10021.99
03:20 ET110721.95
03:25 ET60021.94
03:30 ET42221.88
03:36 ET40021.7801
03:38 ET10021.85
03:39 ET60021.82
03:43 ET40021.91
03:50 ET10021.91
03:52 ET132622.12
03:54 ET30022.21
03:56 ET21922.12
03:57 ET30022.15
03:59 ET42322.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesJSPR
Jasper Therapeutics Inc
333.7M
-3.9x
---
United StatesVRCA
Verrica Pharmaceuticals Inc
316.0M
-4.3x
---
United StatesPGEN
Precigen Inc
388.7M
-4.0x
---
United StatesASPI
ASP Isotopes Inc
163.1M
-5.9x
---
United StatesTELO
Telomir Pharmaceuticals Inc
155.5M
-7.6x
---
United StatesGBLP
Global Pharmatech Inc
138.3M
-3.6x
---
As of 2024-06-23

Company Information

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics targeting mast cell driven diseases, such as Chronic Spontaneous Urticaria (CSU) and Chronic Inducible Urticaria (CIndU). It also has ongoing programs in diseases where targeting diseased hemopoietic stem cells can provide benefits, such as Lower to Intermediate Risk Myelodysplastic Syndrome (LR-MDS), and stem cell transplant conditioning regimens. The Company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (c-Kit) receptor on mast and stem cells. The SCF/c-Kit pathway is a survival signal for mast cells. It is also developing briquilimab as a one-time conditioning therapy for severe combined immunodeficiency (SCID) patients undergoing a second stem cell transplant for which it is conducting a Phase 1/2 clinical trial.

Contact Information

Headquarters
2200 Bridge Pkwy Suite #102REDWOOD CITY, CA, United States 94065
Phone
650-549-1400
Fax
302-636-5454

Executives

Chairman of the Board
Thomas Wiggans
President, Chief Executive Officer, Director
Ronald Martell
Chief Financial Officer, Corporate Secretary
Herb Cross
Chief Operating Officer
Jeetinder Mahal
Director
Scott Brun

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$333.7M
Revenue (TTM)
$0.00
Shares Outstanding
15.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.21
EPS
$-5.60
Book Value
$7.03
P/E Ratio
-3.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.